Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
18°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RGNX
Recent news which mentions RGNX
< Previous
1
2
3
4
Next >
Regenxbio: Q4 Earnings Insights
March 01, 2022
Tickers
RGNX
Tags
RGNX
BZI/Recaps
Market News
From
Benzinga
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
March 01, 2022
Tickers
ABBV
AMRN
AMRS
AVID
Tags
SRPT
NTLA
EPZM
From
Benzinga
Earnings Scheduled For March 1, 2022
March 01, 2022
Tickers
ADT
ADV
AGEN
AIV
Tags
ZIP
MMAT
ADV
From
Benzinga
Earnings Preview: Regenxbio
February 28, 2022
Tickers
RGNX
Tags
RGNX
BZI/EP
Market News
From
Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
Tickers
ACAD
ACLX
AMRN
AMRS
Tags
Earnings
EPZM
KALV
From
Benzinga
RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial
February 09, 2022
Tickers
RGNX
Tags
Market News
gene therapy
Health Care
From
Benzinga
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
February 09, 2022
Tickers
AVRO
AVXL
BMY
DCPH
Tags
AVRO
PYPD
SGEN
From
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Tickers
ABBV
ACLX
ALNY
AMGN
Tags
Food and Drug Administration
IBB
SGEN
From
Benzinga
Expert Ratings For Regenxbio
January 28, 2022
Tickers
RGNX
Tags
Market News
Benzinga
RGNX
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
December 15, 2021
Tickers
ADGI
ALB
AMCR
APEN
Tags
ADGI
PSN
SIX
From
Benzinga
RegenXbio's Duchenne Gene Therapy Secures FDA Orphan Drug Tag
November 22, 2021
Tickers
RGNX
Tags
RGNX
News
Health Care
From
Benzinga
70 Biggest Movers From Yesterday
November 16, 2021
Tickers
AKA
APVO
ATAI
AURA
Tags
Market News
COCO
SOHU
From
Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
November 12, 2021
Tickers
ADPT
AFIB
ANVS
ATHX
Tags
Earnings
Penny Stocks
NVO
From
Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Tickers
ABUS
ACAD
ACIU
ADAP
Tags
ONCS
NVTA
HAE
From
Benzinga
Barron's Latest Picks And Pans: Alleghany, Blade Air Mobility, Gene Therapy Picks And More
November 06, 2021
Tickers
ABBV
BAC
BLDE
COIN
Tags
Barron's
Media
BAC
From
Benzinga
REGENXBIO inc (RGNX) Q3 2021 Earnings Call Transcript
November 03, 2021
Tickers
RGNX
Tags
Market News
RGNX
From
Motley Fool
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
Tickers
AADI
AMGN
AVNS
CNTX
Tags
Market News
TECH
SAGE
From
Benzinga
Earnings Scheduled For November 2, 2021
November 02, 2021
Tickers
LDOS
LEA
LGIH
LILA
Tags
MINM
LUNG
RL
From
Benzinga
Earnings Outlook For Regenxbio
November 01, 2021
Tickers
RGNX
Tags
Benzinga
Earnings
Market News
From
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Tickers
ADPT
AERI
AGIO
ALGS
Tags
ICUI
SGMO
CORT
From
Benzinga
3 High-Yield Dividend Stocks I'm Not Selling Anytime Soon
October 18, 2021
Tickers
ABBV
DVN
EPD
RGNX
Tags
ABBV
Market News
DVN
From
Motley Fool
Regenxbio Reveals Interim Data From Diabetic Retinopathy Gene Therapy Trial
October 11, 2021
Tickers
RGNX
Tags
Small Cap
General
Phase 2 Trial
From
Benzinga
The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage
October 10, 2021
Tickers
AEON
AERI
ALLO
ATRA
Tags
AEON
IBB
FDA
From
Benzinga
44 Biggest Movers From Yesterday
October 05, 2021
Tickers
ADVM
ALVR
AMPY
AMTX
Tags
SBTX
Market News
SALM
From
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 04, 2021
Tickers
ADVM
ALIM
CLNN
OMER
Tags
OMER
Markets
ADVM
From
Benzinga
30 Stocks Moving In Monday's Mid-Day Session
October 04, 2021
Tickers
ADVM
AMPG
AMPY
ARQQ
Tags
SALM
Markets
SBTX
From
Benzinga
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More
October 03, 2021
Tickers
ADVM
ASND
BCYC
CCXI
Tags
Biotech
PRLD
Benzinga
From
Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
Tickers
ADMA
ADVM
AGRX
AGTC
Tags
INZY
ELDN
NXTC
From
Benzinga
Could AbbVie's New Collaboration Be a Blockbuster?
September 27, 2021
Tickers
ABBV
REGN
RGNX
Tags
ABBV
Market News
REGN
From
Motley Fool
Why AbbVie Just Made a $1.8 Billion Gene Therapy Deal
September 25, 2021
Tickers
ABBV
RGNX
Tags
RGNX
ABBV
Market News
From
Motley Fool
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.